Eli Lilly Pitches Alzheimer Drug to the FDA, Aiming to Leapfrog Biogen

·2 min read

It's an exciting if turbulent, and rather cutthroat, time in the world of Alzheimer's drug research. In June, the FDA greenlit Biogen's...

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting